GESSEL advised DataWalk on the issuance of Series S shares worth nearly PLN 60 milion
19.05.2025 Case studies Capital Markets
GESSEL advised DataWalk S.A., a provider of enterprise-class analytics solutions for the public safety and financial sectors, on the issuance of 750,000 Series S ordinary bearer shares with a total value of PLN 58,320,000. The issue was effectuated within the company’s authorized capital, through a non-prospectus public offering addressed to qualified investors and selected retail investors.
The transaction aligns with DataWalk’s strategy for continued growth and strengthening its position in the data analytics market. The funds thus raised will support implementation of DataWalk’s Go2Market structure development strategy. GESSEL provided comprehensive legal advice, including preparation of the full offering documentation and support in fulfilling the issuer’s disclosure obligations.
“Through the Series S share issuance, DataWalk has secured significant capital support, essential for the continued development of its enterprise-class solutions in the field of data analytics and business intelligence. We are pleased to have relied on the to-the-point, swift, and effective support of the GESSEL team, which once again demonstrated its expertise in capital market projects”, said Łukasz Socha, Chief Financial Office at DataWalk.
“Non-prospectus share offerings require not only in-depth knowledge of capital market regulations, but also efficient project execution in a dynamic market environment. We are pleased to have supported DataWalk in this issuance, ensuring full regulatory compliance and operational effectiveness”, added Krzysztof Marczuk, Partner at GESSEL
Lawyers involved in the project
You may also like
09.09.2026
GESSEL advises DCX and its founders on LITEON’s USD 176 million strategic investment
GESSEL advised DCX Polska sp. z o.o. (“DCX Liquid Cooling Systems”), a manufacturer of advanced liquid cooling systems for data centres supporting artificial intelligenc...
08.09.2026
GESSEL advises LUX MED Group on the acquisition of Endomed
GESSEL advised LUX MED sp. z o.o., Poland’s leading private healthcare provider and part of the international Bupa group, on the acquisition of 100% of the shares in End...